The Office of the Attorney General William Tong
Search Results
Page 210 of 214
-
Connecticut Secretary of the State Denise Merrill and Attorney General George Jepsen announced that enforcement efforts against out-of-state companies operating in Connecticut without legal authority have yielded $1.1 million in Fiscal Year 2016. The penalties were paid out by more than 240 companies, the largest fine being $39,630.
-
Attorney General George Jepsen announced today that Connecticut has joined 48 other states and the District of Columbia in a $125 million settlement with biopharmaceutical company Cephalon and its affiliated companies, including Teva Pharmaceutical Industries, Teva Pharmaceuticals USA and Barr Laboratories. The settlement resolves allegations of anticompetitive conduct by Cephalon concerning its drug, Provigil.
-
State Joins Joint State-Federal Settlement with Wyeth Resolving Allegations of Underpaying Rebates
Connecticut will take part in a global $784.6 million settlement with drug-maker Wyeth to resolve allegations that the company knowingly underpaid rebates owed under the Medicaid Drug Rebate Program for the sales of the drug Protonix, Attorney General George Jepsen, Chief State's Attorney Kevin T. Kane and Department of Social Services Commissioner Roderick L. Bremby announced today.
-
"Following this due diligence, it is our firm belief that, if allowed to proceed, this merger would substantially lessen competition for the provision of healthcare insurance services, in that it would have a negative impact on both the availability of competitively priced healthcare and the quality of care in the state of Connecticut."
-
Attorney General George Jepsen and state Department of Consumer Protection Commissioner Michelle H. Seagull today announced that Connecticut has joined with 41 other states and the District of Columbia in a $33 million settlement with Johnson & Johnson and Johnson & Johnson Consumer, Inc. to resolve allegations that the companies engaged in unfair or deceptive trade practices in the marketing of certain over-the-counter medications.
-
State Web site Fights Waste, Fraud and Abuse: Public’s Help Needed
The State of Connecticut has launched a website to help its efforts at fighting fraud, waste and abuse that cost state programs tens of millions of dollars each year.
-
AG Jepsen Leads Coalition Seeking to Intervene, Defend Federal Consumer Financial Protection Bureau
Attorney General George Jepsen today led a group of 16 other attorneys general in filing a motion to intervene in a federal appeals case in order to defend the constitutionality of the federal Consumer Financial Protection Bureau.
-
Attorney General Jepsen Leads Multistate Coalition in $863M State-Federal Settlement with Moody's
Attorney General George Jepsen announced today that Connecticut, the U.S. Department of Justice, 20 other states and the District of Columbia have reached a settlement agreement with Moody's Corporation, Moody's Investor Services, Inc. and Moody's Analytics, Inc. resolving allegations that the credit rating agency mislead investors when it rated structured finance securities in the lead-up to the 2008 financial crisis. The settlement culminates a seven-year effort led by Connecticut to hold Moody's responsible for its role in the 2008 financial crisis.
-
AG Jepsen Joins With Colleagues in Opposing Federal Rule to Subsidize Coal and Nuclear Power Plants
Attorney General George Jepsen has joined a coalition of states to oppose a notice of proposed rulemaking by the U.S. Department of Energy to subsidize aging, economically inefficient coal and nuclear power plants.
-
AG Jepsen Leads Coalition in New, Expanded Complaint in Federal Generic Drug Antitrust Lawsuit
Attorney General George Jepsen today led 45 other attorneys general taking part in a wide-ranging multistate antitrust investigation of the generic drug industry in asking the federal court for permission to file a new complaint in the states' pending lawsuit that increases the number of generic drug manufacturer defendants from six to 18 in the case and the number of drugs at issue in the litigation from two to 15.
-
AG Jepsen: Multistate Investigations Seek Documents from Opioid Manufacturers and Distributors
Attorney General George Jepsen today said that a bipartisan coalition of 39 attorneys general from across the country have demanded information and documents from both the manufacturers and the distributors of prescription opioid drugs.
-
Two former executives of a New Jersey-based generic pharmaceutical manufacturer have entered into settlement and cooperation agreements with 41 states and territories that are investigating what they allege is widespread anticompetitive activity in the generic drug industry that has led to higher prices for consumers and state governments, Attorney General George Jepsen announced today.
-
Attorney General George Jepsen today joined with attorneys general around the country in a letter to credit reporting firm Equifax requesting that it disable links for enrollment in fee-based credit monitoring service in the wake of the massive data breach impacting 143 million people.
-
Attorney General George Jepsen today provided testimony to the legislature's Judiciary Committee in support of Senate Bill 1021, An Act Revising the Uniform Fraudulent Transfer Act, legislation that aims to prevent bankruptcy courts from ordering colleges and universities to pay back money parents or guardians had paid to send their children to college.
-
Statement from Attorney General Jepsen on Reports of Malicious Facebook Video